2.8K
Downloads
39
Episodes
The Mesothelioma Applied Research Foundation developed MesoTV in response to the need to cancel our annual International Symposium on Malignant Mesothelioma. In our first season we covered a number of topics, many focused on the immediate effects of Covid-19 on mesothelioma treatment. In our second season and beyond, we focus on more traditional topics such as advances in treatment, mesothelioma science, the patient and caregiver experience and quality of life.
Episodes
Monday Mar 21, 2022
Monday Mar 21, 2022
We are joined by Dr. Aaron Mansfield of the Mayo Clinic to discuss a new, now enrolling, clinical trial for peritoneal mesothelioma that randomizes patients into two arms: an arm that receives chemotherapy + bevacizumab, and an arm that receives chemotherapy, bevacizumab and immunotherapy.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.